Related Experiment Video
Updated: Sep 10, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neurodevelopmental effects of opioids in preterm infants - A systematic review and meta-analysis of randomised and
Maya Rakshasbhuvankar1, Chandra Rath2, Sachin Agrawal2
1General Paediatrics, Perth Children's Hospital, Western Australia, Australia; Neonatology, King Edward Memorial Hospital for Women, Perth, Western Australia, Australia.
Insights
Opioid use in preterm infants does not appear to increase neurodevelopmental impairment risk. However, evidence is very limited, with some studies suggesting potential negative impacts on motor skills.
Area of Science:
- Neonatalogy
- Developmental Pediatrics
- Pharmacology
Background:
- Opioids are frequently administered to preterm infants for pain and distress management in neonatal intensive care units.
- Concerns exist regarding the potential adverse effects of opioid exposure on infant neurodevelopment.
Purpose of the Study:
- To systematically review randomized controlled trials (RCTs) and observational studies (OSs) investigating the impact of opioids on neurodevelopmental outcomes in preterm infants.
Main Methods:
- A systematic review adhering to Cochrane Collaboration guidelines was performed.
- Included randomized controlled trials (RCTs) and observational studies (OSs).
- Quantitative synthesis (pooling) was used where possible; qualitative synthesis for other data.
Main Results:
- The review encompassed 16 studies (13 OSs, 3 RCTs) with 3173 infants.
- No increased risk of neurodevelopmental impairment was found (very low certainty evidence).
- Lower motor scores were observed in opioid-exposed infants at 2-3 years; qualitative analysis showed variable effects of opioids.
Conclusions:
- The current evidence regarding opioid effects on preterm infant neurodevelopment is inconclusive.
- The certainty of the available evidence is rated as 'very low'.
Background:
Opioids are commonly used to reduce pain and distress in preterm infants in neonatal intensive care units. However, there is a concern that exposure to opioids may adversely affect their neurodevelopment.
Methods:
We conducted a systematic review of randomised controlled trials (RCTs) and observational studies (OSs) to investigate the effect of opioids on neurodevelopmental outcomes in preterm infants. We followed the Cochrane Collaboration guidelines and those for the synthesis of OSs. Results were pooled when at least two studies reported the outcome. We performed a qualitative synthesis for data not suitable for pooling.
Results:
The systematic review included 21 records of 16 studies (13 OSs [n = 2993] and three RCTs [n = 180]). Quantitative analysis was possible for ten studies. The certainty of evidence was 'very low' for all outcomes. The risk of neurodevelopmental impairment, the primary outcome, was not increased in opioid exposed preterm infants (OR: 1.15, 95 % CIs: 0.64, 2.08, 5 OSs, n = 697 and OR: 1.29, 95 % CIs: 0.56, 3.01, 2 RCTs, n = 151). There was no increase in adverse secondary outcomes apart from lower motor scores at 2-3 years of age (MD: -6.19, 85 % CI: -11.26, -1.11, 4 OSs, n = 692) in the opioid group. On qualitative analysis of adjusted data, opioids showed variable effects: ten reports suggested harm, two suggested benefit and two suggested no impact, while the results were inconsistent in three reports.
Conclusion:
The current evidence for the effect of opioids on neurodevelopmental outcomes of preterm infants is inconclusive and of very low certainty.
Related Concept Videos
Factors Affecting Drug Response: Overview
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Teratogenicity

